Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Cochlear Americas Inc.
EIR
•Cochlear Americas Inc.•February 22, 2018

Cochlear Americas Inc. – FDA EIR, Feb 22, 2018

Record Details

Cochlear Americas Inc. underwent a routine FDA inspection from February 2 to February 22, 2018, under the regulatory framework for Sponsors, Contract Research Organizations, and Monitors (CP 7348.810). The inspection focused on the company's oversight of the "Safety and Efficacy of the Cochlear Nucleus CI422 Cochlear Implant" study. An FDA Form 483 was issued, detailing significant observations. A primary violation (21 CFR 812.46(a)) was the company's failure to ensure investigators complied with study agreements and regulatory requirements. Specifically, informed consent forms used at several investigational sites were modified inconsistently, omitting crucial warnings, precautions for the cochlear implant, and statements regarding the clinical trial registry. Some forms also contained unsubstantiated risk percentages. Further issues included inaccurate and incomplete records for anticipated adverse device effects, with at least one serious adverse event not being reported by the sponsor. The company also failed to ensure proper monitoring of the investigational study and consistent Institutional Review Board (IRB) review and approval across all participating sites. Deficiencies in staff training for monitoring activities and missing essential site documentation were also noted. The regulatory implications for Cochlear Americas included potential Warning Letters and the risk of data rejection. This necessitates comprehensive corrective actions such as retraining clinical staff on adverse event reporting, protocol compliance, and informed consent procedures, along with revising operational procedures and enhancing internal reporting and oversight mechanisms for clinical trial sites.

Company
Cochlear Americas Inc.
Inspection date
February 22, 2018
Product type
devices
Office
Denver District Office
People
  • Theressa B. Smith
  • Edward E. Lockwood
  • Anthony Kolesa
  • Christine Drabick
View Company Profile

ID · 513d3fd5-762c-4ed8-9f96-cdc020214105

Other documents for Cochlear Americas Inc.
  • 483 - 2021-10-21October 21, 2021
  • 483 - 2018-02-22February 22, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cochlear Americas Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.